SBS Code
stringlengths 9
11
| SBS Code (Hyphenated)
stringlengths 11
12
| Short Description
stringlengths 3
74
| Long Description
stringlengths 7
544
| Chapter
float64 1
25
⌀ | Chapter Name
stringclasses 25
values | Block
int64 1
4.02k
| Block Name
stringlengths 3
99
⌀ | Definition
stringlengths 11
1.18k
⌀ | Includes
stringlengths 4
1.31k
⌀ | Excludes
stringlengths 1
1.23k
⌀ | Guidelines
stringlengths 1
1.54k
⌀ |
|---|---|---|---|---|---|---|---|---|---|---|---|
733500702 | 73350-07-02 | Bacterial vaginosis & vaginitis screen | Detection of bacterial vaginosis & vaginitis DNA markers of (Gardnerella vaginalis, Atopobium vaginae, Lactobacillus species (L. crispatus & L. jensenii), Megasphaera type 1, Bacterial Vaginosis Associated Bacteria-2 (BVAB-2)) with detection of Trichomonas vaginalis and Candida species by quantitative real-time amplification from vaginal-fluid | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Multianalyte assay with algorithmic analysis (computer based) for BV&vaginitis | Detection of bacterial vaginosis RNA markers of (atopobium vaginae, Gardnerella vaginalis, and Lactobacillus species) by quantitative real-time amplification from vaginal-fluid | null | Do not assign this code with (73050-50-90, 73050-51-00, 73050-51-10, 73050-53-20, 73050-53-30, 73050-53-40, 73050-58-80). This code involve all the molecular tests required to produce the results. Do not separately code the technical lab tests. However, you may code any preparatory work conducted before cell lysis (e.g. microdissection or tissue selection from archived specimens). |
733500703 | 73350-07-03 | HCV; Fibrosis & inflammatory activity | Measurement of hepatitis C virus (HCV) liver fibrosis and necroinflammation activity score by 6 biochemical assays ((A2-macroglobulin, ALT, total bilirubin, apolipoprotein A-1, GGT, and haptoglobin) from serum | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Multianalyte assay with algorithmic analysis (computer based) for HCV liver fibrosis and necroinflammation activity | Measurement of hepatitis C virus (HCV) liver fibrosis and necroinflammation activity score by 6 biochemical assays ((A2-macroglobulin, ALT, Total bilirubin, apolipoprotein A-1, GGT, and haptoglobin) from serum | null | This code involve all the molecular tests required to produce the results. Do not separately code the technical lab tests. However, you may code any preparatory work conducted before cell lysis (e.g. microdissection or tissue selection from archived specimens). |
733500704 | 73350-07-04 | Breast cancer recurrence risk; 11 genes; Quant. | Quantitative measurement of breast cancer metastatic recurrence risk by mRNA gene expression profiling of 11 genes (7 content; 4 housekeeping) utilizing real time polymerase chain reaction (RT-PCR) from formalin-fixed paraffin-embedded breast tumor tissue | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Multianalyte assay with algorithmic analysis (computer based) for cancer metastatic recurrence risk to evaluate potential benefit of extended endocrine therapy. | Quantitative measurement of breast cancer metastatic reccurance risk by mRNA gene epression profiling of 11 genes (7 content; 4 housekeeping) utilizing real time polymerase chain reaction (RT-PCR) from formalin-fied paraffin-embedded breast tumor tissue | null | This code involve all the molecular tests required to produce the results. Do not separately code the technical lab tests. However, you may code any preparatory work conducted before cell lysis (e.g. microdissection or tissue selection from archived specimens). |
733500705 | 73350-07-05 | Breast cancer recurrence risk; 12 genes; Quant. | Quantitative measurement of breast cancer metastatic recurrence risk by mRNA gene expression profiling of 12 genes (8 content; 4 housekeeping) utilizing real time polymerase chain reaction (RT-PCR) from formalin-fixed paraffin-embedded tissue | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Multianalyte assay with algorithmic analysis (computer based) for cancer metastatic recurrence risk | Quantitative measurement of breast cancer metastatic reccurance risk by mRNA gene epression profiling of 12 genes (8 content; 4 housekeeping) utilizing real time polymerase chain reaction (RT-PCR) from formalin-fied paraffin-embedded tissue | null | This code involve all the molecular tests required to produce the results. Do not separately code the technical lab tests. However, you may code any preparatory work conducted before cell lysis (e.g. microdissection or tissue selection from archived specimens). |
733500706 | 73350-07-06 | Breast cancer recurrence risk; 21 genes; Quant. | Quantitative measurement of breast cancer metastatic recurrence risk by mRNA gene expression profiling of 21 genes utilizing real time polymerase chain reaction (RT-PCR) from formalin-fixed paraffin-embedded breast tumor tissue | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Multianalyte assay with algorithmic analysis (computer based) for cancer metastatic recurrence risk to evaluate recurrence of malignancy after surgery. | Quantitative measurement of breast cancer metastatic reccurance risk by mRNA gene epression profiling of 21 genes utilizing real time polymerase chain reaction (RT-PCR) from formalin-fied paraffin-embedded breast tumor tissue | null | This code involve all the molecular tests required to produce the results. Do not separately code the technical lab tests. However, you may code any preparatory work conducted before cell lysis (e.g. microdissection or tissue selection from archived specimens). |
733500707 | 73350-07-07 | Breast cancer recurrence risk; 58 genes; Quant. | Quantitative measurement of breast cancer metastatic recurrence risk for 58 genes (50 content; 8 housekeeping) by real time polymerase chain reaction (RT-PCR) from formalin-fixed paraffin-embedded breast tumor tissue | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Multianalyte assay with algorithmic analysis (computer based) for cancer metastatic recurrence risk | Quantitative measurement of breast cancer metastatic reccurance risk for 58 genes (50 content; 8 housekeeping) by real time polymerase chain reaction (RT-PCR) from formalin-fied paraffin-embedded breast tumor tissue | null | This code involve all the molecular tests required to produce the results. Do not separately code the technical lab tests. However, you may code any preparatory work conducted before cell lysis (e.g. microdissection or tissue selection from archived specimens). |
733500708 | 73350-07-08 | Breast cancer recurrence risk; 535 genes; Quant. | Quantitative measurement of breast cancer metastatic recurrence risk by mRNA gene expression profiling of 535 genes (70 content; 465 housekeeping) utilizing real time polymerase chain reaction (RT-PCR) from formalin-fixed paraffin-embedded breast tumor tissue | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Multianalyte assay with algorithmic analysis (computer based) for cancer distance metastatic recurrence risk | Quantitative measurement of breast cancer metastatic reccurance risk by mRNA gene epression profiling of 535 genes (70 content; 31, 465 housekeeping) utilizing real time polymerase chain reaction (RT-PCR) from formalin-fied paraffin-embedded breast tumor tissue | null | Do not assign this code in addition to (Breast Cancer Recurrence Risk; 101 genes) |
733500709 | 73350-07-09 | Breast cancer recurrence risk; 101 genes; Quant. | Quantitative measurement of breast cancer metastatic recurrence risk by mRNA gene expression profiling of 101 genes (70 content; 31 housekeeping) utilizing real time polymerase chain reaction (RT-PCR) from formalin-fixed paraffin-embedded breast tumor tissue | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Multianalyte assay with algorithmic analysis (computer based) for cancer distant metastatic recurrence risk | null | null | Do not assign this code in addition to (Breast Cancer Recurrence Risk; 535 genes) |
733500710 | 73350-07-10 | Colorectal Cancer Screen | Detection of colorectal cancer 10 DNA markers (KRAS mutations, promoter methylation of NDRG4 & BMP3) and fecal hemoglobin by quantitative real-time target and signal amplification; from stool | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Multianalyte assay with algorithmic analysis (computer based) for colorectal cancer utilizing detection DNA markers and fecal blood for evaluation of asymptomatic patients for colorectal cancer | null | null | Do not assign this code with (73050-05-00, KRAS Gene; Exon 2 Variants). This code involve all the molecular tests required to produce the results. Do not separately code the technical lab tests. However, you may code any preparatory work conducted before cell lysis (e.g. microdissection or tissue selection from archived specimens). |
733500711 | 73350-07-11 | Colon Cancer Recurrence risk | Measurement of colon cancer recurrence risk for 12 genes (7 content; 5 housekeeping) by real time polymerase chain reaction (RT-PCR) from formalin-fixed paraffin-embedded colon tumor tissue | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Multianalyte assay with algorithmic analysis (computer based) for cancer recurrence risk following resection | null | null | This code involve all the molecular tests required to produce the results. Do not separately code the technical lab tests. However, you may code any preparatory work conducted before cell lysis (e.g. microdissection or tissue selection from archived specimens). |
733500712 | 73350-07-12 | Cutaneous Melanoma risk | Measurement of cutaneous melanoma recurrence risk by mRNA gene expression profiling of 31 genes (28 content; 3 housekeeping) utilizing real time polymerase chain reaction (RT-PCR) from formalin-fixed paraffin-embedded tissue | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Melanoma recurrence risk | null | null | This code involve all the molecular tests required to produce the results. Do not separately code the technical lab tests. However, you may code any preparatory work conducted before cell lysis (e.g. microdissection or tissue selection from archived specimens). |
733500713 | 73350-07-13 | Tumor drug response; Gynecologic; 1st Drug | Tumor susceptibility to drug or chemotherapeutic agent; analysis of response score (1st single drug or drug combination) from female gynecological specimen, by cell staining with 4’–6–diamidino–2–phenylindole (DAPI) and morphology evaluation | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Test for tumor susceptibility to chemotherapy agent (chemotherapeutic response) | null | null | This code involve all the molecular tests required to produce the results. Do not separately code the technical lab tests. However, you may code any preparatory work conducted before cell lysis (e.g. microdissection or tissue selection from archived specimens). |
733500714 | 73350-07-14 | Tumor drug response; Gynecologic; additional drugs | Tumor susceptibility to drug or chemotherapeutic agent; analysis of response score (Additional single drug or drug combination) from female gynecological specimen, by cell staining with 4’–6–diamidino–2–phenylindole (DAPI) and morphology evaluation (Additional code) | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Test for tumor susceptibility to chemotherapy agent (chemotherapeutic response) | null | null | This is an additional code to be assigned with (Tumor Drug Response; Gynecologic; 1st Drug). Assign this code for each drug response score. Do not report this code alone. |
733500715 | 73350-07-15 | Lung cancer survival liklihood | Evaluation of lung cancer survival likelihood (good vs. poor) for eight proteins (including amyloid) by mass spectrometry from serum | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Multianalyte assay with algorithmic analysis (computer based) for lung cancer survival likelihood | null | null | This code involve all the molecular tests required to produce the results. Do not separately code the technical lab tests. However, you may code any preparatory work conducted before cell lysis (e.g. microdissection or tissue selection from archived specimens). |
733500721 | 73350-07-21 | Prostate cancer mortality risk | Measurement of prostate cancer mortality risk by mRNA gene expression profiling of 46 genes (31 content; 15 housekeeping) utilizing real time polymerase chain reaction (RT-PCR) from formalin-fixed paraffin-embedded prostate tumor tissue | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Multianalyte assay with algorithmic analysis (computer based) for prostate cancer mortality risk or prediction of post–prostatectomy recurrence risk. (mRNA gene expression profiling) | null | null | This code involve all the molecular tests required to produce the results. Do not separately code the technical lab tests. However, you may code any preparatory work conducted before cell lysis (e.g. microdissection or tissue selection from archived specimens). |
733500722 | 73350-07-22 | Prostate cancer metastatic risk | Measurement of prostate metastatic risk by mRNA microarray gene expression profiling for 22 genes (31 content; 15 housekeeping) utilizing real time polymerase chain reaction (RT-PCR) from formalin-fixed paraffin-embedded prostate tumor tissue | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Multianalyte assay with algorithmic analysis (computer based) for prostate cancer metastatic risk (mRNA gene expression profiling) | null | null | This code involve all the molecular tests required to produce the results. Do not separately code the technical lab tests. However, you may code any preparatory work conducted before cell lysis (e.g. microdissection or tissue selection from archived specimens). |
733500723 | 73350-07-23 | Prostate cancer metastatic risk; methylation profile | Measurement of prostate metastatic risk by promoter methylation profiling for 3 genes (GSTP1, APC, RASSF1) utilizing real time polymerase chain reaction (RT-PCR) from formalin-fixed paraffin-embedded prostate tumor tissue | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Multianalyte assay with algorithmic analysis (computer based) for prostate cancer metastatic risk to help in decision making for when to perform repeat prostate biopsy. | null | null | This code involve all the molecular tests required to produce the results. Do not separately code the technical lab tests. However, you may code any preparatory work conducted before cell lysis (e.g. microdissection or tissue selection from archived specimens). |
733500724 | 73350-07-24 | Thyroid cancer risk | Measurement of thyroid cancer risk (benign or suspicious) by mRNA gene expression profiling for 10196 genes from fine needle aspirate specimen | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Thyroid cancer risk | null | null | This code involve all the molecular tests required to produce the results. Do not separately code the technical lab tests. However, you may code any preparatory work conducted before cell lysis (e.g. microdissection or tissue selection from archived specimens). |
733500260 | 73350-02-60 | HBB gene; variants | Hemoglobin subunit beta (HBB) gene variant analysis (e.g. HbS, HbC, HbE) | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Testing for mutation detection (e.g. sickle cell anemia, beta thalassemia, hemoglobinopathy) | null | null | null |
733500270 | 73350-02-70 | HBB gene; Familial variant | Hemoglobin subunit beta (HBB) analysis of common familial variant | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Analysis of specific, familial, gene sequence alteration (variant/mutation) (e.g. sickle cell anemia, beta thalassemia, hemoglobinopathy) | null | null | null |
733500280 | 73350-02-80 | HBB gene; Dup/Del | Hemoglobin subunit beta (HBB) duplication and deletion variant analysis | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Testing for analysis of repeated or deleted nucleotides (e.g. sickle cell anemia, beta thalassemia, hemoglobinopathy) | null | null | null |
733500290 | 73350-02-90 | HBB gene; Full sequence | Hemoglobin subunit beta (HBB) full sequence analysis | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Full sequencing of a gene (e.g. sickle cell anemia, beta thalassemia, hemoglobinopathy) | null | null | null |
733500300 | 73350-03-00 | HLA (I&II) typing; all class I Loci; LR | Low resolution analysis of human leukocyte antigen genes (HLA) of all Class I loci (HLA-A, HLA-B, HLA-C) and all Class II (HLA–DRB1, HLA–DRB3/4/5, and HLA-DQB1) | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Identification of target HLA gene sequences (e.g. donor/recipient compatibility ) | null | null | Do not use these codes for HLA typing by serology, instead refer to HLA typing in the hematology section |
733500310 | 73350-03-10 | HLA (I&II) Typing; Specific Loci; LR | Low resolution analysis of certain loci for human leukocyte antigen genes (HLA) specific Class I loci (HLA-A, HLA-B) and Class II (HLA–DRB1) | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Identification of target HLA gene sequences, specific alleles or loci (e.g. donor/recipient compatibility ) | null | null | When a kit for typing (HLA–A, HLA–B), and (HLA–DRB1) also tests for (HLA–DRB3/4/5), do not additionally report the –DRB3/4/5 assessment as it is included in this code. |
733500320 | 73350-03-20 | HLA (I) typing; all class I & class II Loci; LR | Low resolution analysis of human leukocyte antigen genes (HLA) of all Class I loci (HLA-A, HLA-B, HLA-C) | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Identification of target HLA gene sequences (e.g. donor/recipient compatibility ) | null | null | null |
733500330 | 73350-03-30 | HLA (I) Typing; one locus; LR | Low resolution analysis of human leukocyte antigen genes (HLA) of one Class I locus (HLA-A OR HLA-B OR HLA-C) | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Identification of target HLA gene sequences (e.g. donor/recipient compatibility) | null | null | Assign this code for each tested loci; however, if testing involves all three loci (HLA-A, HLA-B, HLA-C) assign (73350-03-00, HLA (I) Typing; All Loci; LR) instead |
733500340 | 73350-03-40 | HLA (I) Typing; Specific allele; LR | Low resolution analysis of human leukocyte antigen genes (HLA) of one Class I antigen equivalent (allele group of interest) based on specific disease (e.g. B*27) | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Identification of target HLA gene sequences based on disease of interest. (e.g. B*27 for ankylosing spondylitis, an inflammatory joint condition). | null | null | Assign code for each HLA(I) antigen equivalent (e.g. B*27). If more than two antigen equivalents are on the same locus, assign (73350-03-30, HLA (I) Typing; one Locus; LR) instead |
733500350 | 73350-03-50 | HLA (II) Typing; All loci; LR | Low resolution analysis of human leukocyte antigen genes (HLA) all Class II (HLA–DRB1/3/4/5, and HLA-DQB1) | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Identification of target HLA gene sequences (e.g. donor/recipient compatibility ) | null | null | null |
733500360 | 73350-03-60 | HLA (II) Typing; One locus; LR | Low resolution analysis of human leukocyte antigen genes (HLA) of one Class II locus (HLA–DRB1, or HLA–DRB3/4/5, or HLA–DQB1, or HLA–DQA, or HLA–DPB1, or HLA–DPA1) | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Identification of target HLA gene sequences (e.g. donor/recipient compatibility) | null | null | Assign this code for each tested loci, (HLA–DRB3/4/5 is considered one locus); however, if testing involves all loci (HLA–DRB1/3/4/5 and HLA–DQB1) assign (73350-03-50, HLA (II) Typing; All Loci; LR) instead. |
733500370 | 73350-03-70 | HLA (II) Typing; Specific Allele; LR | Low resolution analysis of human leukocyte antigen genes (HLA) of one Class II, antigen equivalent (one allele group of interest) associated with specific disease (e.g. DRB1*15) | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Identification of target HLA gene sequences associated with certain conditions (e.g. DRB1*15 for with multiple sclerosis). | null | null | Assign code for each HLA(I) antigen equivalent (e.g. DRB1*15). If more than two antigen equivalents are on the same locus, assign (73350-03-60, HLA (II) Typing; one Locus; LR) instead. |
733500380 | 73350-03-80 | HLA (I&II) Typing; All Loci; HR | High resolution analysis of human leukocyte antigen genes (HLA) of all Class I (HLA-A, HLA-B, HLA-C) and all Class II (HLA–DRB1) | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Identification of target HLA gene sequences (e.g. donor/recipient compatibility) | null | null | null |
733500390 | 73350-03-90 | HLA (I) Typing; All Loci; HR | High resolution analysis of human leukocyte antigen genes (HLA) of all Class I loci (HLA-A, HLA-B, HLA-C) | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Identification of target HLA gene sequences (e.g. donor/recipient compatibility) | null | null | null |
733500400 | 73350-04-00 | HLA (I) Typing; One Locus; HR | High resolution analysis of human leukocyte antigen genes (HLA) of one Class I locus (HLA-A OR HLA-B OR HLA-C) | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Identification of target HLA gene sequences, including more than 2 alleles or allele groups (e.g. donor/recipient compatibility). | null | null | null |
733500410 | 73350-04-10 | HLA (I) Typing; Specific Allele; HR | High resolution analysis of human leukocyte antigen genes (HLA) of one Class I antigen equivalent (one allele or allele group of interest) based on specific disease (e.g. B*57:01P) | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Identification of target HLA gene sequences based on disease of interest (e.g. B*57:01P for drug carbamazepine hypersensitivity) | null | null | Assign code for each allele or allele groups (e.g. B*57:01P). If more than two alleles are on the same locus, assign (73350-04-00, HLA (I) Typing; one Locus; HR) instead. |
733500420 | 73350-04-20 | HLA (II) Typing; One Locus; HR | High resolution analysis of human leukocyte antigen genes (HLA) of one Class II locus (HLA–DRB1, or HLA–DRB3/4/5, or HLA–DQB1, or HLA–DQA, or HLA–DPB1, or HLA–DPA1) | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Identification of target HLA gene sequences (e.g. donor/recipient compatibility) | null | null | Assign this code for each tested loci (e.g. HLA–DRB1, HLA–DRB3/4/5, HLA–DQB1, HLA–DQA1, HLA–DPB1, or HLA–DPA1) ( HLA–DRB3/4/5 is considered one locus) |
733500430 | 73350-04-30 | HLA (II) Typing; Specific Allele; HR | High resolution analysis of human leukocyte antigen genes (HLA) of one Class II, antigen equivalent (one allele or allele group of interest) associated with specific disease (e.g. DQB1*06:02P) | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Identification of target HLA gene sequences associated with certain conditions (e.g. DQB1*06:02P for narcolepsy). | null | null | Assign code for each allele or allele groups (e.g. DQB1*06:02P). If more than two alleles are present on the same locus, Assign (73350-04-20, HLA (I) Typing; HLA (II) Typing; one Locus; HR) instead. |
733500440 | 73350-04-40 | Level 1 - molecular pathology proc | Level 1 involving single variant analysis (single nucleotide polymorphisms (SNPs)) by restriction enzyme digestion or melt curve techniques | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Nucleic acid extraction, amplification, and detection of target genes by various methods | null | null | null |
733500450 | 73350-04-50 | Level 2 - molecular pathology proc | Level 2 involving identification of 2–10 single nucleotide polymorphisms (SNPs), single methylated or somatic variant by non–sequencing techniques, or a dynamic mutation with trinucleotide repeats | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Nucleic acid extraction, amplification, and detection of target genes by various methods | null | null | null |
733500460 | 73350-04-60 | Level 3 - molecular pathology proc | Level 3 involving identification of more than 10 single nucleotide polymorphisms (SNPs), 2-10 somatic variants by non–sequencing techniques, immunoglobulin or T cell receptor rearrangements, one exon duplication/deletions, loss of heterozygosity (LOH) testing, uniparental disomy (UPD). | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Nucleic acid extraction, amplification, and detection of target genes by various methods | null | null | null |
733500470 | 73350-04-70 | Level 4 - molecular pathology proc | Level 4 involving sequencing one specific DNA exon; analysis of more than 10 amplification products by two or more reactions using polymerase chain reaction (PCR); DNA scanning for mutation identification in 2-5 exons; duplication/deletion variant evaluation from 2-5 exons. | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Nucleic acid extraction, amplification, and detection of target genes by various methods | null | null | null |
733500480 | 73350-04-80 | Level 5 - molecular pathology proc | Level 5 involving sequencing 2-5 specific DNA exons, DNA scanning for mutation identification in 6-10 exons, duplication/deletion variant evaluation from 6-10 exons, dynamic mutation(with trinucleotide repeats) Southern blot analysis.
| 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Nucleic acid extraction, amplification, and detection of target genes by various methods | null | null | null |
733500490 | 73350-04-90 | Level 6 - molecular pathology proc | Level 6 involving sequencing 6-10 specific DNA exons, DNA scanning for mutation identification in 11-25 exons, duplication/deletion variant evaluation from 11-25 exons, or use of cytogenomic array analysis for a certain chromosomal region. | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Nucleic acid extraction, amplification, and detection of target genes by various methods | null | null | null |
733500500 | 73350-05-00 | Level 7 - molecular pathology proc | Level 7 involving sequencing 11-25 specific DNA exons, DNA scanning for mutation identification in 26-50 exons, duplication/deletion variant evaluation from 26-50 exons | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Nucleic acid extraction, amplification, and detection of target genes by various methods | null | null | null |
733500510 | 73350-05-10 | Level 8 - molecular pathology proc | Level 8 involving sequencing 26-50 specific DNA exons, DNA scanning for mutation identification in 50 exons, duplication/deletion variant evaluation from 50 exons, or utilizing multiple gene sequence analyses by a complex testing platform. | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Nucleic acid extraction, amplification, and detection of target genes by various methods | null | null | null |
733500520 | 73350-05-20 | Level 9 - molecular pathology proc | Level 9 involving sequencing more than 50 specific DNA exons in a single gene | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Nucleic acid extraction, amplification, and detection of target genes by various methods | null | null | null |
733500530 | 73350-05-30 | Fetal chromosome aneuploidy panel | Fetal Chromosome Aneuploidy (e.g. monosomy X, Trisomy 21); genomic sequence analysis panel, including (chromosomes 13, 18, and 21) | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Fetal chromosomal abnormality panel for analysis of circulating cell free fetal DNA from maternal blood (e.g. down syndrome..etc.) | null | null | Do not assign this code with (WGS by NGS, Genome Analysis by CMA; CNV&SNP, Cytogenetic Test by FISH ) |
733500540 | 73350-05-40 | Fetal chromosome microdeletions | Fetal Chromosome Microdeletions; genomic sequence analysis panel | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Fetal chromosomal abnormality panel for analysis of circulating cell free fetal DNA from maternal blood (e.g. DiGeorge syndrome, Cri-du-chat syndrome) | null | null | Do not assign this code with (WGS by NGS, Genome Analysis by CMA; CNV&SNP, Cytogenetic Test by FISH ) |
733500550 | 73350-05-50 | Genome analysis | Genome (e.g unexplained disorder); gene sequence analysis | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Whole genome analysis for detection of variants potentially causing unexplained disorder | null | null | Do not assign this code with (WGS by NGS). It is possible to report all or any of the following codes together based on the performed testing (Genome Analysis, Genome Analysis; Comparator Reference, Genome Re-Evaluation) |
733500560 | 73350-05-60 | Genome analysis; comparator reference | Genome (e.g unexplained disorder); creation of reference genome (e.g. parent or sibling) gene sequence (Additional code) | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Reference genome creation (from parent, sibling, relative) for comparison to patient in order to evaluate unexplained disorders | null | null | Do not assign this code with (WGS by NGS). This is an additional code to be assigned with (Genome Analysis). Do not report this code alone. It is possible to report all or any of the following codes together based on the performed testing (Genome Analysis, Genome Analysis; Comparator Reference, Genome Re-Evaluation) |
733500570 | 73350-05-70 | Genome re-evaluation | Re-evaluation of existing genome gene sequence (previously obtained) | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Reevaluation of patient genome due to emergence of new information | null | null | It is possible to report all or any of the following codes together based on the performed testing (Genome Analysis, Genome Analysis; Comparator Reference, Genome Re-Evaluation) |
733500580 | 73350-05-80 | Hereditary breast cancer panel | Hereditary Breast Cancer disorders (e.g. hereditary breast cancer/ovarian cancer/endometrial cancer); gene sequence analysis panel of minimum 10 genes, including (BRCA1, BRCA2, CDH1, MLH1, MSH2, MSH6, PALB2, PTEN, STK11, and TP53). | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Genomic sequencing analysis of multiple genes for multiple disorders involving methods as Next Generation Sequencing | null | null | null |
733500590 | 73350-05-90 | Hereditary breast cancer; Dup/Del Panel | Hereditary Breast Cancer disorders (e.g. hereditary breast cancer/ovarian cancer/endometrial cancer); duplication/deletion analysis panel, including (BRCA1, BRCA2, MLH1, MSH2, and STK11). | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Duplication/deletion analysis of multiple genes for multiple disorders involving methods as Multiplex Ligation dependent Probe Amplification (MLPA) | null | null | Do not separately code each of the genes listed in this panel. |
733500600 | 73350-06-00 | Unlist molecular dx proc | Unlisted molecular diagnostic procedure | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Unlisted or unspecified molecular pathology procedure | null | null | null |
733500610 | 73350-06-10 | RA activity | Measurement of rheumatoid arthritis (RA) disease activity score for 12 serum biomarkers by immunoassays | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Multianalyte assay with algorithmic analysis for RA activity indicators | null | null | This code involve all the molecular tests required to produce the results. Do not separately code the technical lab tests. However, you may code any preparatory work conducted before cell lysis (e.g. microdissection or tissue selection from archived specimens). |
733500620 | 73350-06-20 | Ovarian Cancer risk; 2Proteins | Measurement of ovarian cancer risk score for two proteins (cancer antigen 125 (CA-125) and human epididymis protein 4 (HE4)) by biochemical assays from serum with menopausal status | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Multianalyte assay with algorithmic analysis (computer based) for Risk of Ovarian Malignancy Algorithm (ROMA) | null | null | Do not assign this code with (73100-14-00, 73100-14-10)This code involve all the molecular tests required to produce the results. Do not separately code the technical lab tests. However, you may code any preparatory work conducted before cell lysis (e.g. microdissection or tissue selection from archived specimens). |
733500630 | 73350-06-30 | Ovarian Cancer risk; 5Proteins | Measurement of ovarian cancer risk score for 5 proteins (CA-125, apolipoprotein A1, beta-2 microglobulin, pre-albumin, and transferrin) by biochemical assays from serum with menopausal status | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Multianalyte assay with algorithmic analysis (computer based) for Risk of Ovarian Malignancy Algorithm (ROMA) | null | null | Do not assign this code with (73050-03-60, 73050-04-00, 73050-29-20, 73050-36-10, 73100-14-00). This code involve all the molecular tests required to produce the results. Do not separately code the technical lab tests. However, you may code any preparatory work conducted before cell lysis (e.g. microdissection or tissue selection from archived specimens). |
733500650 | 73350-06-50 | Fetal aneuploidy risk | Measurement of fetal aneuploidy (trisomies 13, 18 and 21) risk score by micro assay from pregnant maternal plasma | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Multianalyte assay with algorithmic analysis (computer based) for Fetal aneuploidy (e.g. trisomy 21 Down syndrome, trisomy 18 Edwards syndrome, and trisomy 13 Patau syndrome). | null | null | Do not assign this code with (73200-05-30, Genome Analysis by CMA; CNV, Genome Analysis by CMA; CNV&SNP). This code involve all the molecular tests required to produce the results. Do not separately code the technical lab tests. However, you may code any preparatory work conducted before cell lysis (e.g. microdissection or tissue selection from archived specimens). |
733500660 | 73350-06-60 | Fetal congenital abnormality risk; 2Proteins | Measurement of fetal congenital abnormalities risk score by biochemical assay for 2 proteins (Pregnancy–associated plasma protein–A (PAPP-A), and human Chorionic Gonadotropin (hCG) from maternal serum | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Multianalyte assay with algorithmic analysis (computer based) for Fetal congenital abnormalities (e.g. first trimester down syndrome screen) | null | null | Do not assign this code with (73050-30-80, 73050-39-30). This code involve all the molecular tests required to produce the results. Do not separately code the technical lab tests. However, you may code any preparatory work conducted before cell lysis (e.g. microdissection or tissue selection from archived specimens). |
733500670 | 73350-06-70 | Fetal congenital abnormality risk; 3Proteins | Measurement of fetal congenital abnormalities risk score by biochemical assay for 3 proteins (Pregnancy–associated plasma protein–A (PAPP-A), and human Chorionic Gonadotropin (hCG), dimeric inhibin A(DIA)) from maternal serum | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Multianalyte assay with algorithmic analysis (computer based) for Fetal congenital abnormalities (e.g. second trimester down syndrome screen) | null | null | Do not assign this code with (73050-30-80, 73050-39-30, 73100-15-70). This code involve all the molecular tests required to produce the results. Do not separately code the technical lab tests. However, you may code any preparatory work conducted before cell lysis (e.g. microdissection or tissue selection from archived specimens). |
733500680 | 73350-06-80 | Fetal congenital abnormality risk; 3Analytes | Measurement of fetal congenital abnormalities risk score by biochemical assay for 3 analytes (alpha–fetoprotein (AFP), unconjugated estriol (uE3), human Chorionic Gonadotropin(hCG)) from maternal serum | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Multianalyte assay with algorithmic analysis (computer based) for Fetal congenital abnormalities (e.g. second trimester down syndrome and open neural tube defects screen) | null | null | Do not assign this code with (73050-01-70, 73050-12-00, 73050-39-30). This code involve all the molecular tests required to produce the results. Do not separately code the technical lab tests. However, you may code any preparatory work conducted before cell lysis (e.g. microdissection or tissue selection from archived specimens). |
733500690 | 73350-06-90 | Fetal congenital abnormality risk; 4Analytes | Measurement of fetal congenital abnormalities risk score by biochemical assay for 4 analytes (alpha–fetoprotein (AFP), unconjugated estriol (uE3), human Chorionic Gonadotropin(hCG, dimeric inhibin A (DIA)) from maternal serum | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Multianalyte assay with algorithmic analysis (computer based) for Fetal congenital abnormalities (e.g. second trimester down syndrome and open neural tube defects screen) | null | null | Do not assign this code with (73050-01-70, 73050-12-00, 73050-39-30, 73100-15-70). This code involve all the molecular tests required to produce the results. Do not separately code the technical lab tests. However, you may code any preparatory work conducted before cell lysis (e.g. microdissection or tissue selection from archived specimens). |
733500700 | 73350-07-00 | Fetal congenital abnormality risk; 5Analytes | Measurement of fetal congenital abnormalities risk score by biochemical assay for 5 analytes (alpha–fetoprotein (AFP), unconjugated estriol (uE3), total and hyperglycosylated human Chorionic Gonadotropin(hCG, dimeric inhibin A (DIA)) from maternal serum | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Multianalyte assay with algorithmic analysis (computer based) for Fetal congenital abnormalities (e.g. down syndrome and open neural tube defects screen) | null | null | Do not assign this code with (73050-01-70, 73050-12-00, 73050-39-30, 73100-15-70). This code involve all the molecular tests required to produce the results. Do not separately code the technical lab tests. However, you may code any preparatory work conducted before cell lysis (e.g. microdissection or tissue selection from archived specimens). |
733500720 | 73350-07-20 | High grade prostate cancer risk | Measurement of high-grade prostate cancer (Gleason 7 or higher) probability risk score for four proteins (Total prostate specific antigen (PSA), Free PSA, Intact PSA, and human kallikrein-2 [hK2]) by biochemical assays from plasma or serum | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Multianalyte assay with algorithmic analysis (computer based) for high grade prostate cancer probability score | null | null | This code involve all the molecular tests required to produce the results. Do not separately code the technical lab tests. However, you may code any preparatory work conducted before cell lysis (e.g. microdissection or tissue selection from archived specimens). |
734000421 | 73400-04-21 | Mature oocyte cryopreservation | Cryopreservation (freezing) of mature female Oocyte (eggs) | 21 | Laboratory and Pathology | 3,400 | Fertility Medicine, In Vivo and Other Lab Procedures | Preservation of eggs (for future use) by freezing; for infertility high-risk patients (E.g. patients undergoing chemotherapy or radiation therapy. | null | null | null |
734000000 | 73400-00-00 | Transcutaneous bilirubin; Total | Transcutaneous measurement of total Bilirubin | 21 | Laboratory and Pathology | 3,400 | Fertility Medicine, In Vivo and Other Lab Procedures | Non invasive measurement of total bilirubin levels (e.g. hyperbilirubinemia, jaundice) | null | null | null |
734000010 | 73400-00-10 | Transcutaneous hemoglobin | Quantitative transcutaneous measurement of hemoglobin (Hgb) | 21 | Laboratory and Pathology | 3,400 | Fertility Medicine, In Vivo and Other Lab Procedures | Non invasive measurement of hemoglobin levels (e.g. hgb monitoring for anemia). | null | null | null |
734000020 | 73400-00-20 | Transcutaneous carboxyhemoglobin | Quantitative transcutaneous measurement of carboxyhemoglobin | 21 | Laboratory and Pathology | 3,400 | Fertility Medicine, In Vivo and Other Lab Procedures | Non invasive measurement of carboxyhemoglobin levels (e.g. carbon monoxide poisoning). | null | null | null |
734000030 | 73400-00-30 | Transcutaneous Methemoglobin | Quantitative Transcutaneous Measurement of Methemoglobin | 21 | Laboratory and Pathology | 3,400 | Fertility Medicine, In Vivo and Other Lab Procedures | Non invasive measurement of methemoglobin levels (e.g. adverse anesthesia reactions). | null | null | null |
734000040 | 73400-00-40 | Unlist in vivo proc | Unlisted in vivo laboratory procedure | 21 | Laboratory and Pathology | 3,400 | Fertility Medicine, In Vivo and Other Lab Procedures | Unlisted or unspecified in vivo (e.g. transcutaneous) procedure | null | null | null |
734000050 | 73400-00-50 | Caffeine halothane contracture test (CHCT) | Test for malignant hyperthermia (MH) susceptibility with interpretation and report (genetic disorder) | 21 | Laboratory and Pathology | 3,400 | Fertility Medicine, In Vivo and Other Lab Procedures | Test utilizing muscle biopsy specimen for evaluation of MH | null | null | null |
734000060 | 73400-00-60 | CSF; Cell count | Cell counting for miscellaneous body fluids (e.g. cerebrospinal fluid, joint fluid, pleural fluid) excluding blood | 21 | Laboratory and Pathology | 3,400 | Fertility Medicine, In Vivo and Other Lab Procedures | CSF cell count (e.g. gout, meningitis, infection, inflammation, congestive heart failure) | null | null | null |
734000070 | 73400-00-70 | CSF; Cell & differential count | Cell count with differential count for miscellaneous body fluids (e.g. cerebrospinal fluid, joint fluid, pleural fluid) excluding blood | 21 | Laboratory and Pathology | 3,400 | Fertility Medicine, In Vivo and Other Lab Procedures | CSF cell and differential count for measuring the amounts of white blood cells (e.g. fluid collection suspected due to cancer or infection) | null | null | null |
734000080 | 73400-00-80 | Leukocyte analysis stool; Quant./Qual. | Quantitative/Qualitative analysis for leukocytes in stool specimen | 21 | Laboratory and Pathology | 3,400 | Fertility Medicine, In Vivo and Other Lab Procedures | Test for presence of white blood cells (e.g. colitis, intestinal infection) | null | null | null |
734000090 | 73400-00-90 | Crystal identification | Analysis of tissue or body fluid (excluding urine) for presence of crystals utilizing light microscopy | 21 | Laboratory and Pathology | 3,400 | Fertility Medicine, In Vivo and Other Lab Procedures | Crystal identification (e.g. gout, painful joints) from knee fluid specimen | null | null | Do not assign this code for crystal identification on paraffin-embedded tissue. You may also assign (73200-00-00) if performed. |
734000100 | 73400-01-00 | Fat stain | Fat staining for analysis of urine, feces, or respiratory secretions specimens | 21 | Laboratory and Pathology | 3,400 | Fertility Medicine, In Vivo and Other Lab Procedures | Fat stain (e.g. prolonged diarrhea, liver problems, cystic fibrosis) | null | null | null |
734000110 | 73400-01-10 | Meat fibers; Stool | Microscopic examination for meat fibers in feces | 21 | Laboratory and Pathology | 3,400 | Fertility Medicine, In Vivo and Other Lab Procedures | Analysis for presence of meat fibers after meat consumption (e.g. malabsorption, Whipple disease) | null | null | null |
734000120 | 73400-01-20 | Eosinophils nasal smear | Nasal smear examination for presence of eosinophils | 21 | Laboratory and Pathology | 3,400 | Fertility Medicine, In Vivo and Other Lab Procedures | Nasal smear to evaluate presence of white blood cell due to allergies and parasitic infections. | null | null | null |
734000130 | 73400-01-30 | Sputum collection | Collection of sputum specimen (e.g. saliva, mucus, or pus) by aerosol mist induced technique | 21 | Laboratory and Pathology | 3,400 | Fertility Medicine, In Vivo and Other Lab Procedures | Collection of sputum sample (e.g. bacterial cultures for pneumonia or tuberculosis). | null | null | only assign if performed as a separate procedure, not as part of another procedure. |
734000140 | 73400-01-40 | Sweat collection | Collection of sweat specimen (e.g. saliva, mucus, or pus) by iontophoresis technique | 21 | Laboratory and Pathology | 3,400 | Fertility Medicine, In Vivo and Other Lab Procedures | Collection of sweat sample (e.g. history of CF, salty sweat, chronic cough, recurrent respiratory infections). | null | null | null |
734000150 | 73400-01-50 | Unlist clinical pathology proc | Unlisted clinical pathology procedure | 21 | Laboratory and Pathology | 3,400 | Fertility Medicine, In Vivo and Other Lab Procedures | Unlisted or unspecified Miscellaneous Pathology Procedure | null | null | null |
734000160 | 73400-01-60 | CultureOocyte/Embryo | Culture of Oocyte (eggs) or embryos for fewer than 4 days | 21 | Laboratory and Pathology | 3,400 | Fertility Medicine, In Vivo and Other Lab Procedures | Preparation of optimum environment for oocyte/embryo culture to produce viable embryos suitable for implantation | Culture of both frozen or fresh oocytes/embryos | null | Include culture of both frozen or fresh oocytes/embryos |
734000170 | 73400-01-70 | Culture/co-cultureOocyte/embryo | Culture of Oocyte (eggs) or embryos for fewer than 4 days with co-culture | 21 | Laboratory and Pathology | 3,400 | Fertility Medicine, In Vivo and Other Lab Procedures | Preparation of optimum environment for oocyte/embryo culture (with co-culture feeder cells, i.e. (granulosa,
endometrial, tubal, etc.)) to produce viable embryos suitable for implantation | Culture of both frozen or fresh oocytes/embryos | null | Include culture of both frozen or fresh oocytes/embryos |
734000180 | 73400-01-80 | Assisted hatching | Assisted embryo hatching procedure utilizing microtechniques (e.g. zona dissection) | 21 | Laboratory and Pathology | 3,400 | Fertility Medicine, In Vivo and Other Lab Procedures | Assisted hatching of embryo for implantation purposes | null | null | null |
734000190 | 73400-01-90 | Oocyte identification | Oocyte (egg) identification from ovarian fluid | 21 | Laboratory and Pathology | 3,400 | Fertility Medicine, In Vivo and Other Lab Procedures | Presence of oocytes for in vitro fertilization (IVF) | null | null | Report one code per identification service, regardless of oocyte numbers |
734000200 | 73400-02-00 | Embryo transfer preparation | Preparation for embryo transfer to the uterus | 21 | Laboratory and Pathology | 3,400 | Fertility Medicine, In Vivo and Other Lab Procedures | Embryo transfer preparation | null | null | null |
734000210 | 73400-02-10 | Sperm identification; Aspirate | Identification of sperm from aspiration (all sources except seminal fluid) | 21 | Laboratory and Pathology | 3,400 | Fertility Medicine, In Vivo and Other Lab Procedures | Sperm identification by aspiration method (e.g. MESA, PESA, and TESA) | null | null | null |
734000220 | 73400-02-20 | Embryo cryopreservation | Embryo cryopreservation (freezing and preservation) | 21 | Laboratory and Pathology | 3,400 | Fertility Medicine, In Vivo and Other Lab Procedures | Freezing and storage of embryos | null | null | null |
734000230 | 73400-02-30 | Sperm cryopreservation | Sperm cryopreservation (freezing and preservation) | 21 | Laboratory and Pathology | 3,400 | Fertility Medicine, In Vivo and Other Lab Procedures | Freezing and storage of sperm | null | null | null |
734000240 | 73400-02-40 | Sperm isolation w/ simple prep | Sperm isolation by simple preparation techniques (e.g. swim up, sperm wash) with semen analysis, for insemination or identification of sperm abnormalities | 21 | Laboratory and Pathology | 3,400 | Fertility Medicine, In Vivo and Other Lab Procedures | Sperm isolation by simple preparation technique for insemination or diagnosis purposes (part of In vitro fertilization IVF) | Work for semen analysis | null | Includes work for semen analysis (e.g. count & motility evaluation) |
734000250 | 73400-02-50 | Sperm isolation w/ complex prep | Sperm isolation by complex preparation techniques (e.g. Albumin gradient, Percoll gradient) with semen analysis, for insemination or identification of sperm abnormalities | 21 | Laboratory and Pathology | 3,400 | Fertility Medicine, In Vivo and Other Lab Procedures | Sperm isolation by complex preparation technique for insemination or diagnosis purposes (part of In vitro fertilization IVF) | Work for semen analysis | null | Includes work for semen analysis (e.g. count & motility evaluation) |
734000260 | 73400-02-60 | Sperm identification; fresh/frozen tissue | Identification of sperm from fresh or frozen testis tissue | 21 | Laboratory and Pathology | 3,400 | Fertility Medicine, In Vivo and Other Lab Procedures | Identification of sperm from fresh tissue (e.g. by testicular sperm extraction (TESE)) or from cryopreserved tissue. This test is typically ordered for infertility treatment | null | null | null |
734000270 | 73400-02-70 | Egg fertilization | Egg fertilization (oocyte Insemination) | 21 | Laboratory and Pathology | 3,400 | Fertility Medicine, In Vivo and Other Lab Procedures | Oocyte insemination for eggs retrieved during an in vitro fertilization(IVF) procedure protocol | null | null | null |
734000280 | 73400-02-80 | Extended oocyte/embryo Culture | Extended oocyte or embryo culture (4-7 days) | 21 | Laboratory and Pathology | 3,400 | Fertility Medicine, In Vivo and Other Lab Procedures | Incubation for extended amount of time (4-7 days) for one or more oocytes or embryos as part of in vitro maturation (IVM) protocol | null | null | null |
734000290 | 73400-02-90 | Assisted oocyte fertilization; ≤10 eggs | Assisted fertilization of oocyte by microtechnique method (e.g. intracytoplasmic sperm injection (ICSI)) for up to 10 oocytes. | 21 | Laboratory and Pathology | 3,400 | Fertility Medicine, In Vivo and Other Lab Procedures | Assisted insemination of oocyte | null | null | null |
734000300 | 73400-03-00 | Assisted oocyte fertilization; >10 eggs | Assisted fertilization of oocyte by microtechnique method (e.g. intracytoplasmic sperm injection (ICSI)) for more than 10 oocytes. | 21 | Laboratory and Pathology | 3,400 | Fertility Medicine, In Vivo and Other Lab Procedures | Assisted insemination of oocyte | null | null | null |
734000310 | 73400-03-10 | PGD bx ; ≤5 eggs/embryos | Oocyte polar body biopsy or blastomere biopsy by microtechnique method of up to 5 oocytes/embryos, for Preimplantation genetic testing (PGD) | 21 | Laboratory and Pathology | 3,400 | Fertility Medicine, In Vivo and Other Lab Procedures | Biopsy to screen for genetic disorders | Biopsy only | Culture or transfer preparation | This service Includes biopsy only. It does not include culture or transfer preparation |
734000320 | 73400-03-20 | PGD bx ; >5 eggs/embryos | Oocyte polar body biopsy or embryo blastomere biopsy by microtechnique method of more than 5 oocytes/embryos, for Preimplantation genetic testing (PGD) | 21 | Laboratory and Pathology | 3,400 | Fertility Medicine, In Vivo and Other Lab Procedures | Biopsy to screen for genetic disorders | Biopsy only | Culture or transfer preparation | This service Includes biopsy only. It does not include culture or transfer preparation |
734000330 | 73400-03-30 | Semen analysis; sims-huhner test | Semen analysis of sperm presence & motility with Sims-Huhner test (postcoital test (PCT)) | 21 | Laboratory and Pathology | 3,400 | Fertility Medicine, In Vivo and Other Lab Procedures | Evaluation of semen characteristics | null | null | null |
734000340 | 73400-03-40 | Semen analysis; Motility & count | Semen analysis of sperm motility and count | 21 | Laboratory and Pathology | 3,400 | Fertility Medicine, In Vivo and Other Lab Procedures | Evaluation of semen characteristics | null | Huhner test | null |
734000350 | 73400-03-50 | Semen analysis; volume motility & count | Semen analysis of sperm volume, sperm count, differential count, and motility | 21 | Laboratory and Pathology | 3,400 | Fertility Medicine, In Vivo and Other Lab Procedures | Evaluation of semen characteristics | null | null | null |